Tags » Pharma

Novartis gets the edge in lung cancer race with fast review for Zykadia

Novartis’ Zykadia has been granted priority review by the FDA for first-line treatment of a subset of lung cancer patients. 

The drug now only has a six-month wait for a regulatory decision instead of the usual 10 months. 298 more words

Pharma

Graphic Designer for a Pharma Co. (Goregaon West, Mumbai)

We have a position for graphic designer with a Pharma Co. headquartered at Goregaon West,

Mumbai.

Post Offered:Graphic Designer

CTC: 2.0 Lacs PA to 3.00 Lacs PA… 145 more words

Pharma/ API/ Bulk Drug Openings

Jr./Officer Microbiologist for an API Plant (Mahad, Maharashtra)

We have an opening for Officer-Microbiology with a well reputed API Plant at Mahad. Please find the details below:

Position: Officer /Jr. Officer Microbiologist… 195 more words

Pharma/ API/ Bulk Drug Openings

Research Officer for an API Plant (Mahad, Maharashtra)

We have an opening with a well reputed API Mfg Co. for their plant at Mahad. Please find the details below:

Position: Research Officer (3 positions) 104 more words

Pharma/ API/ Bulk Drug Openings

Accounts & MIS Head for a Fast Growing Pharma Co. (Andheri West, Mumbai)

We have an urgent requirement for Accounts & MIS Head with a well reputed fast growing pharma co. Headquartered at Andheri West, Mumbai. Please find the details below: 330 more words

Pharma

How to Aim for Raw Materials Protection?

If you are in biopharmaceutical protecting raw materials is an important thing and one that should considered as very seriously, if not managed properly may result to product shortages and plant close downs – stopping from instances like microbial or virus contamination – can be far reaching and difficult to get over. 356 more words

Pharma

NICE says yes to Novartis' Afinitor in kidney cancer

Novartis’ Afinitor (everolimus) has received backing from UK cost-effectiveness body NICE for routine use in patients with advanced kidney cancer. 

The drug is now available as a second-line treatment in cases of advanced renal cell carcinoma that has progressed during or following treatment with vascular endothelial growth factor (VEGF)-targeted therapy. 294 more words

Pharma